Ras, PI(3)K and mTOR signalling controls tumour cell growth
Top Cited Papers
- 24 May 2006
- journal article
- review article
- Published by Springer Nature in Nature
- Vol. 441 (7092) , 424-430
- https://doi.org/10.1038/nature04869
Abstract
All eukaryotic cells coordinate cell growth with the availability of nutrients in their environment. The mTOR protein kinase has emerged as a critical growth-control node, receiving stimulatory signals from Ras and phosphatidylinositol-3-OH kinase (PI(3)K) downstream from growth factors, as well as nutrient inputs in the form of amino-acid, glucose and oxygen availability. Notably, components of the Ras and PI(3)K signalling pathways are mutated in most human cancers. The preponderance of mutations in these interconnected pathways suggests that the loss of growth-control checkpoints and promotion of cell survival in nutrient-limited conditions may be an obligate event in tumorigenesis.Keywords
This publication has 83 references indexed in Scilit:
- TOR Signaling in Growth and MetabolismCell, 2006
- Wild-Type and Mutant B-RAF Activate C-RAF through Distinct Mechanisms Involving HeterodimerizationMolecular Cell, 2005
- Oncogenic PI3K deregulates transcription and translationNature Reviews Cancer, 2005
- A Genetic Screen Identifies PITX1 as a Suppressor of RAS Activity and TumorigenicityCell, 2005
- RAS Is Regulated by the let-7 MicroRNA FamilyPublished by Elsevier ,2005
- Guilty as charged: B-RAF is a human oncogenePublished by Elsevier ,2004
- Signaling Specificity by Ras Family GTPases Is Determined by the Full Spectrum of Effectors They RegulateMolecular and Cellular Biology, 2004
- Targeting the PI3K-Akt pathway in human cancerCancer Cell, 2003
- NF1 Tumor Suppressor Gene Function: Narrowing the GAPPublished by Elsevier ,2001
- Signalling networks that cause cancerTrends in Cell Biology, 1999